Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo

RNA

Volumn 19, Issue 1, 2013, Pages 116-127

  Somarelli, Jason A ^a   Schaeffer, Daneen ^a   Bosma, Reggie ^a   Bonano, Vivian I ^a,b   Sohn, Jang Wook ^a,c   Kemeny, Gabor ^a   Ettyreddy, Abhinav ^a   Garcia Blanco, Mariano A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Korea University   (South Korea)

Author keywords

DsRed; Enhanced green fluorescent protein; Epithelial mesenchymal transition; In vivo imaging; pre mRNA splicing; Wound healing

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL FATE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; WOUND CLOSURE;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EXONS; FLUORESCENCE; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; WHOLE BODY IMAGING; WOUND HEALING;

MUS MUSCULUS;

EID: 84871420608     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.035097.112     Document Type: Article

References (35)

1. Baraniak AP, Lasda EL, Wagner EJ, Garcia-Blanco MA. 2003. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol 23: 9327-9337.
2. Baraniak AP, Chen JR, Garcia-Blanco MA. 2006. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol 26: 1209-1222.
3. Bonano VI, Oltean S, Brazas RM, Garcia-Blanco MA. 2006. Imaging the alternative silencing of FGFR2 exon IIIb in vivo. RNA 12: 2073-2079.
4. Bonano VI, Oltean S, Garcia-Blanco MA. 2007. A protocol for imaging alternative splicing regulation in vivo using fluorescence reporters in transgenic mice. Nat Protoc 2: 2166-2181.
5. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM. 2004. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 6: 395-404.
6. Chen CM, Krohn J, Bhattacharya S, Davies B. 2011. A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS ONE 6: e23376. doi: 10.1371/journal.pone.0023376.
7. David CJ, Manley JL. 2010. Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev 24: 2343-2364.
8. Dell KR, Williams LT. 1992. A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem 267: 21225-21229.
9. Feng S, Wang F, Matsubara A, Kan M, McKeehan WL. 1997. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57: 5369-5378.
10. Gal A, Sjoblom T, Fedorova L, Imreh S, Beug H, Moustakas A. 2008. Sustained TGF β exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27: 1218-1230.
11. Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K, et al. 2011. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene 31: 3190-3201.
12. Kemp PR, Ellis PD, Smith CW. 2005. Visualization of alternative splicing in vivo. Methods 37: 360-367.
13. Kuroyanagi H, Ohno G, Sakane H, Maruoka H, Hagiwara M. 2010. Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans. Nat Protoc 5: 1495-1517.
14. Marek L, Ware KE, Fritzsche A, Hercule P, Helton WR, Smith JE, McDermott LA, Coldren CD, Nemenoff RA, Merrick DT, et al. 2009. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells. Mol Pharmacol 75: 196-207.
15. Mauger DM, Lin C, Garcia-Blanco MA. 2008. hnRNP H and hnRNP F Complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Mol Cell Biol 28: 5403-5419.
16. Mazzalupo S, Wawersik MJ, Coulombe PA. 2002. An ex vivo assay to assess the potential of skin keratinocytes for wound epithelialization. J Invest Dermatol 118: 866-870.
17. Mehta AK, Majumdar SS, Alam P, Gulati N, Brahmachari V. 2009. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 428: 20-24.
18. Muh SJ. 2002. A non-sequence-specific double-stranded RNA structural element regulates splicing of two mutually exclusive exons of fibroblast growth factor receptor 2 (FGFR2). J Biol Chem 277: 50143-50154.
19. Nakamura M, Tokura Y. 2011. Epithelial-mesenchymal transition in the skin. J Dermatol Sci 61: 7-13.
20. Oltean S. 2006. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci 103: 14116-14121.
21. Oltean S, Febbo PG, Garcia-Blanco MA. 2008. Dunning rat prostate adenocarcinomas and alternative splicing reporters: Powerful tools to study epithelial plasticity in prostate tumors in vivo. Clin Exp Metastasis 25: 611-619.
22. Pilcher BK, Gaither-Ganim J, Parks WC, Welgus HG. 1997. Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. A common receptor pathway. J Biol Chem 272: 18147-18154.
23. Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP. 1994. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 5: 851-862.
24. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB. 2011. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218. doi: 10.1371/journal.pgen.1002218.
25. TAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain. BMC Neurosci 10: 86. doi: 10.1186/1471-2202-10-86.
26. Strathdee D, Ibbotson H, Grant SG. 2006. Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS ONE 1: e4. doi: 10.1371/journal.pone.0000004.
27. Takeuchi A, Hosokawa M, Nojima T, Hagiwara M. 2010. Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection. PLoS ONE 5: e10946. doi: 10.1371/journal.pone. 0010946.
28. Turner N, Grose R. 2010. Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer 10: 116-129.
29. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, Ghigna C, Biamonti G. 2010. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191: 87-99.
30. Verkhusha VV, Kuznetsova IM, Stepanenko OV, Zaraisky AG, Shavlovsky MM, Turoverov KK, Uversky VN. 2003. High stability of Discosoma DsRed as compared to Aequorea EGFP. Biochemistry 42: 7879-7884.
31. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
32. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. 2009. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33: 591-601.
33. Wawersik MJ, Mazzalupo S, Nguyen D, Coulombe PA. 2001. Increased levels of keratin 16 alter epithelialization potential of mouse skin keratinocytes in vivo and ex vivo. Mol Biol Cell 12: 3439-3450.
34. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams LT. 1994. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266: 819-822.
35. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.